SALTIRE II and RANKL Inhibition in Aortic Stenosis

Trial Profile

SALTIRE II and RANKL Inhibition in Aortic Stenosis

Phase of Trial: Phase II

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs Denosumab (Primary) ; Alendronic acid
  • Indications Aortic valve stenosis
  • Focus Therapeutic Use
  • Acronyms SALTIRE II
  • Most Recent Events

    • 02 Dec 2014 Status changed from not yet recruiting to recruiting as reported by record.
    • 10 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top